| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Options Exercise | $0 | +8.99K | +7.62% | $0.00 | 127K | Feb 1, 2025 | Direct | |
| transaction | LLY | Common Stock | Tax liability | -$3.25M | -4K | -3.16% | $811.08 | 123K | Feb 1, 2025 | Direct | |
| holding | LLY | Common Stock | 72.4K | Feb 1, 2025 | By Trust | F1 | |||||
| holding | LLY | Common Stock | 3.26K | Feb 1, 2025 | By spouse | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -8.99K | -100% | $0.00 | 0 | Feb 1, 2025 | Common Stock | 8.99K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |